Araştırma Makalesi

Analysis of telomere length in patients with COVID-19 and investigation into its relationship with clinical- demographic data

Cilt: 48 Sayı: 3 30 Eylül 2023
PDF İndir
EN TR

Analysis of telomere length in patients with COVID-19 and investigation into its relationship with clinical- demographic data

Abstract

Purpose: Novel coronavirus disease 2019 (COVID-19) is an infectious disease unknown before the 2019 outbreak in Wuhan. This study evaluated telomere length in COVID-19 (+) and (-) samples with clinical-demographic parameters. Materials and Methods: DNA was isolated from COVID-19 (+) (n=70) and (-) (n=70) patients. Telomere length was determined by real-time-PCR (RT-PCR). The 2–∆∆Ct method was used to analyze the telomere length of the samples. Results: There were significant differences in creatinine, LDH, ferritin, WBC, NEU and CRP in COVID-19 (+) patients compared to COVID-19 (-) patients. The NEU/LYM (or N/L) ratio was found higher in the patients with COVID-19 (+), than in COVID-19 (-). On the other hand, our COVID-19 (+) patients (mean±std:0.93±0.58) had significantly shorter telomere lengths than the COVID-19 (-) (mean±std:1.26±0.76). Moreover, COVID-19 (+) male patients (mean±std:1.06±0.50) had longer telomere length than female patients (mean±std:0.76±0.54). Telomere length was significantly shorter in patients with COVID-19 (+)with high blood urea nitrogen (BUN), high creatinine, high hematocrit, high NEU levels, normal platelets (PLT), and low WBC levels. Conclusions: Our findings suggest that telomere length and blood parameter levels influence the severity of COVID-19. Blood parameters differed in patients with COVID-19 (+) and COVID-19 (-). As a result, increasing the number of similar studies in the future can demonstrate the significance of our findings. Keywords: COVID-19, Telomere length, RT-PCR, NEU/LYM, blood

Keywords

COVID-19 , Telomere length , RT-PCR , NEU/LYM , blood

Kaynakça

  1. Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71-6.
  2. Mitra A, Ray Chaudhuri T, Mitra A, Pramanick P, Zaman S. Impact of COVID-19 related shutdown on atmospheric carbon dioxide level in the city of Kolkata. Parana J Sci Educ. 2020;6:84-92.
  3. Veer IMM, Riepenhausen A, Zerban M, Wackerhagen C, Puhlmann LMCMC, Engen H et al. Psycho-social factors associated with mental resilience in the Corona lockdown. Transl Psychiatry. 2021;11:67.
  4. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al. A Novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-33.
  5. Touma M. COVID-19: molecular diagnostics overview. J Mol Med (Berl). 2020;98:947-54.
  6. Kempuraj D, Selvakumar GPP, Ahmed MEE, Raikwar SPP, Thangavel R, Khan A et al. COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation. Neuroscientist. 2020;26:402-14.
  7. Debuc B, Smadja DM. Is COVID-19 a new hematologic disease? Stem Cell Rev Reports. 2021;17:4-8.
  8. Tjendra Y, Al Mana AF, Espejo AP, Akgun Y, Millan NC, Gomez-Fernandez C et al. Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers. Arch Pathol Lab Med. 2020;144:1465-74.
  9. Dirican E, Savrun ŞT, Aydın İE, Gülbay G, Karaman Ü. Analysis of mitochondrial DNA cytochrome‐b ( CYB ) and ATPase‐6 gene mutations in COVID‐19 patients. J Med Virol. 2022;94:3138-46.
  10. Connell NTT, Battinelli EMM, Connors JMM. Coagulopathy of COVID‐19 and antiphospholipid antibodies. J Thromb Haemost. 2020;18:E1-2.

Kaynak Göster

MLA
Savrun, Atakan, ve Ebubekir Dirican. “Analysis of telomere length in patients with COVID-19 and investigation into its relationship with clinical- demographic data”. Cukurova Medical Journal, c. 48, sy 3, Eylül 2023, ss. 833-4, doi:10.17826/cumj.1312436.